CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy - Wikidata - wikimedia - TriplyDB

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

http://www.wikidata.org/entity/Q24649764

about

Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Amyloidosis: pathogenesis and new therapeutic options.Chronic alloantibody mediated rejection.FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.Immunophenotyping in multiple myeloma and related plasma cell disorders.Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.Targeting B cells and antibody in transplantation Management of myeloma-associated renal dysfunction in the era of novel therapies.B-cell regulation and its application to transplantation.siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.Viewing Extrinsic Proteotoxic Stress Through the Lens of Amyloid Cardiomyopathy.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.Activating and inhibitory Fcγ receptors in immunotherapy: being the actor or being the target

P2860

Q26827340-A0A3D822-1F4D-48CE-988A-C0C11F2B9630 Q33399238-8CF7AF8C-A25F-49E0-A48C-699A676ABC2C Q34448455-5DE98F3A-F90A-420A-B035-1A3CC6C472C8 Q35111771-2BE3C3B2-97EA-4B79-AD26-E3F53BDED0E2 Q37058050-A20B71EC-B716-4D26-91CC-7F4FC7199296 Q37736263-11F2346C-7537-4A31-BB96-F6560EF3C1E1 Q37812870-7EAB92C0-A18D-488C-B01A-349A3E99EA35 Q37832199-B14C19DF-2F62-4A3A-A3A2-65FBA816B094 Q37888770-789E8210-6F6D-43F6-9444-6B36D18AA100 Q37978343-193DE38E-918E-4BEF-8FE6-98DB62EEFFF1 Q38126085-B16E9202-AAFD-4390-9B82-B7AD4634F2E3 Q38759595-4563E52B-77DD-4409-8002-BB45A45585EF Q38851025-92A8D730-7A5F-4DE4-ACE4-AD53BA3E66C3 Q38928383-B08D4405-B987-43A8-9BEB-2F0D669A361E Q41734624-1C368412-2CEB-432C-92A1-2C6E9E61A8FE Q47125786-FF301E40-44E6-41B0-852D-7DF51153378B Q51804210-443CA03C-256A-48D2-ACA7-F25176AD20AE Q57583344-195883FA-DE38-4A4F-851E-905D3F8720A5

P2860

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

http://www.wikidata.org/entity/Q24649764

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@ast

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@en

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@nl

type

label

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@ast

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@en

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@nl

prefLabel

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@ast

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@en

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@nl

P1433

Q24649764-7C60EED3-29E1-499D-8506-892FF51ACC9D

P1476

Q24649764-CE2EA3F2-D716-4A23-BC95-6BDE571850DD

P2093

Q24649764-0FD5F748-C14C-493F-A0B1-78DAF03F29BB

Q24649764-23D8F8BB-88BC-46B2-85B3-9773599F597F

Q24649764-30D56037-94FD-493E-A316-B03DD742CD39

Q24649764-4A103D4E-531E-4D6C-A8D2-CA1E41839943

Q24649764-5F38B12D-BC0E-47F2-8008-A3F321F1D302

Q24649764-66552652-C426-41DC-AE10-5F1DE44544A4

Q24649764-A3D59228-0AAB-4E0A-8E32-B3FB6AAD9F95

Q24649764-A744C125-05A7-4135-8E51-199F42ECE700

Q24649764-CCD7ED7E-452D-4C67-8659-7AC5F70B6D76

Q24649764-EB2728FA-9411-4CA5-B98E-A84B93C4504A

P2860

Q24649764-2937BCA6-3742-4172-BF70-B74C388206EC

Q24649764-2EF0196A-3156-4365-BDED-418501411809

Q24649764-3578296B-3651-4503-98DE-45095CFCFE05

Q24649764-37AF6F98-D8B5-4DFA-AAD4-74D8F0389C87

Q24649764-3DD48D6D-90D7-4DDD-B88A-1FA80F69847E

Q24649764-52A980A3-7072-4691-B345-B704071B5F59

Q24649764-55094FAE-3255-427C-B296-E82118F2150B

Q24649764-588702CA-FF6D-4E3D-9786-A2AAF335B2E6

Q24649764-92E5793D-3ECF-44D6-8487-722F78CFD769

Q24649764-9347C6E9-702B-451C-B327-D208157806C2

P304

Q24649764-0B187C2A-6862-4793-96EA-779429CA3446

P31

Q24649764-99596AE4-CBEE-42B6-9A13-6620B7ECE4DF

P356

Q24649764-89281728-91D9-4336-9FBC-5B24BC6C730E

P407

Q24649764-AD3B09B2-108D-4423-8ECD-A00B05E5AA1B

P433

Q24649764-6BC2BB9E-2679-49E2-B1B5-07EE07391FB8

P478

Q24649764-B03D58CC-55D6-4E8E-81CD-8A018920DE36

P577

Q24649764-2127DB31-303C-48B0-B0D2-5AFA396C8FAB

P5875

Q24649764-0C56C3AA-4FEB-4508-8765-CBC972CB0BF2

P698

Q24649764-DDFC37D7-FA89-407F-AE54-E038D25B06DC

P921

Q24649764-0E9B53C5-BAE2-48A9-A705-200ED64A3783

Q24649764-A5635AEF-8150-4B77-A8FE-E6DE91200A2E

P932

Q24649764-B3673845-77D1-49EC-807A-CD6C8CFD1DF6

P356

BLOOD-2007-11-125526

P1433

P1476

CD32B is highly expressed on c ...... oclonal antibody-based therapy

@en

P2093

Adam B Olshen

http://www.w3.org/2001/XMLSchema#string

Adam M Boruchov

http://www.w3.org/2001/XMLSchema#string

Ezio Bonvini

http://www.w3.org/2001/XMLSchema#string

James Hoffman

http://www.w3.org/2001/XMLSchema#string

James W Young

http://www.w3.org/2001/XMLSchema#string

Martin Fleisher

http://www.w3.org/2001/XMLSchema#string

Peter G Maslak

http://www.w3.org/2001/XMLSchema#string

Ping Zhou

http://www.w3.org/2001/XMLSchema#string

Raymond L Comenzo

http://www.w3.org/2001/XMLSchema#string

Scott Koenig

http://www.w3.org/2001/XMLSchema#string

P2860

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions

Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization

The antiinflammatory activity of IgG: the intravenous IgG paradox

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.

The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.

Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan.

Transplantation for amyloidosis.

P304

3403-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-11-125526

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5636026

http://www.w3.org/2001/XMLSchema#string

P698

18216299

http://www.w3.org/2001/XMLSchema#string

P921

P932

2275009

http://www.w3.org/2001/XMLSchema#string